BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 18835946)

  • 1. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.
    Bacha F; Lee S; Gungor N; Arslanian SA
    Diabetes Care; 2010 Oct; 33(10):2225-31. PubMed ID: 20592052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
    Osei K; Schuster DP
    Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.
    Osei K; Gaillard T; Schuster DP
    Diabetes Care; 1997 Mar; 20(3):396-404. PubMed ID: 9051394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.
    Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):468-76. PubMed ID: 12522327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents.
    Cali' AM; Bonadonna RC; Trombetta M; Weiss R; Caprio S
    J Clin Endocrinol Metab; 2008 May; 93(5):1767-73. PubMed ID: 18303080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
    Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
    Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function across the spectrum of glucose tolerance in obese youth.
    Weiss R; Caprio S; Trombetta M; Taksali SE; Tamborlane WV; Bonadonna R
    Diabetes; 2005 Jun; 54(6):1735-43. PubMed ID: 15919795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes.
    Kim JY; Bacha F; Tfayli H; Michaliszyn SF; Yousuf S; Arslanian S
    Diabetes Care; 2019 Feb; 42(2):265-272. PubMed ID: 30455334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum.
    Kim JY; Tfayli H; Bacha F; Lee S; Gebara N; Arslanian S
    Metabolism; 2020 Nov; 112():154346. PubMed ID: 32835760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study.
    Giannini C; Weiss R; Cali A; Bonadonna R; Santoro N; Pierpont B; Shaw M; Caprio S
    Diabetes; 2012 Mar; 61(3):606-14. PubMed ID: 22315322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
    Ahrén B; Pacini G
    Am J Physiol; 1997 Oct; 273(4):E701-7. PubMed ID: 9357798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Lipolysis, Diminished Adipose Tissue Insulin Sensitivity, and Impaired β-Cell Function Relative to Adipose Tissue Insulin Sensitivity in Obese Youth With Impaired Glucose Tolerance.
    Kim JY; Nasr A; Tfayli H; Bacha F; Michaliszyn SF; Arslanian S
    Diabetes; 2017 Dec; 66(12):3085-3090. PubMed ID: 28887312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
    Mari A; Pacini G; Murphy E; Ludvik B; Nolan JJ
    Diabetes Care; 2001 Mar; 24(3):539-48. PubMed ID: 11289482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.